Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support gene-edited cell therapy exa-cel, formerly known as CTX001™. | September 28, 2022
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor - read this article along with other careers information, tips and advice on BioSpace
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland's I-270 Biotech Corridor · BioBuzz biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.
Expanded facilities illustrate MaxCyte’s commitment to Montgomery County and the state of Maryland, building the life sciences community, and propelling.
Expanded facilities illustrate MaxCyte’s commitment to Montgomery County and the state of Maryland, building the life sciences community, and propelling local